These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 11920259
1. Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose. Pocock C, Szydlo R, Davis J, de La Fuente J, Craddock C, Cwynarski K, Olavarria E, Rezvani K, Kanfer E, Apperley J, Goldman J. Hematol J; 2001; 2(4):265-72. PubMed ID: 11920259 [Abstract] [Full Text] [Related]
2. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM. Blood; 1995 Nov 01; 86(9):3590-7. PubMed ID: 7579468 [Abstract] [Full Text] [Related]
3. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM. J Clin Oncol; 1997 May 01; 15(5):1767-77. PubMed ID: 9164184 [Abstract] [Full Text] [Related]
4. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ. Am J Med; 2001 Apr 01; 110(5):339-46. PubMed ID: 11286947 [Abstract] [Full Text] [Related]
5. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J, Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation EBMT. Hematol J; 2001 Apr 01; 2(6):363-70. PubMed ID: 11920275 [Abstract] [Full Text] [Related]
6. Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Muramatsu H, Kojima S, Yoshimi A, Atsuta Y, Kato K, Nagatoshi Y, Inoue M, Koike K, Kawase T, Ito M, Kurosawa H, Tanizawa A, Tono C, Hamamoto K, Hotta N, Watanabe A, Morishima Y, Kawa K, Shimada H. Biol Blood Marrow Transplant; 2010 Feb 01; 16(2):231-8. PubMed ID: 19800016 [Abstract] [Full Text] [Related]
7. Treatment of CML with unrelated donor marrow transplant. McGlave P. Leuk Lymphoma; 1993 Feb 01; 11 Suppl 1():209-11. PubMed ID: 8251898 [Abstract] [Full Text] [Related]
8. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Morariu-Zamfir R, Rocha V, Devergie A, Socié G, Ribaud P, Esperou H, Parquet N, Guardiola P, Dal Cortivo L, Bittencourt H, Garnier F, Traineau R, Marolleau JP, Chevret S, Gluckman E. Bone Marrow Transplant; 2001 Mar 01; 27(6):575-80. PubMed ID: 11319585 [Abstract] [Full Text] [Related]
9. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf EW. J Clin Oncol; 2009 Apr 01; 27(10):1644-52. PubMed ID: 19224849 [Abstract] [Full Text] [Related]
10. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A. Bone Marrow Transplant; 1997 Jul 01; 20(1):11-9. PubMed ID: 9232250 [Abstract] [Full Text] [Related]
11. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Carreras E, Tomás JF, Sanz G, Iriondo A, Boqué C, López J, Cabrera R, Sureda A, de Soria VG, Sierra J, Sanz MA, Torres A. Haematologica; 2000 May 01; 85(5):530-8. PubMed ID: 10800172 [Abstract] [Full Text] [Related]
12. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes. Enright H, Davies S, McGlave P. Clin Transpl; 1994 May 01; ():283-93. PubMed ID: 7547549 [Abstract] [Full Text] [Related]
13. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P. Vnitr Lek; 2006 Dec 01; 52(12):1172-80. PubMed ID: 17299910 [Abstract] [Full Text] [Related]
14. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney. Atkinson K, Dodds AJ, Concannon AJ, Milliken S, Downs K, Marshall G, Wilson F, Staniforth D. Aust N Z J Med; 1993 Oct 01; 23(5):450-7. PubMed ID: 8297273 [Abstract] [Full Text] [Related]
15. Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Dini G, Lamparelli T, Rondelli R, Lanino E, Barbanti M, Costa C, Manfredini L, Guidi S, Rosti G, Alessandrino EP, Locatelli F, Marenco P, Soligo D, Di Bartolomeo P, Aversa F, La Nasa G, Busca A, Majolino I, De Laurenzi A, Bacigalupo A. Br J Haematol; 1998 Jul 01; 102(2):544-52. PubMed ID: 9695972 [Abstract] [Full Text] [Related]
16. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A. Bone Marrow Transplant; 1993 Nov 01; 12(5):509-16. PubMed ID: 8298562 [Abstract] [Full Text] [Related]
17. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, Frassoni F, Gahrton G, Kolb HJ, Niederwieser D, Ruutu T, Vernant JP, de Witte T, Apperley J. Lancet; 1998 Oct 03; 352(9134):1087-92. PubMed ID: 9798583 [Abstract] [Full Text] [Related]
18. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Bone Marrow Transplant; 1997 May 03; 19(10):1001-9. PubMed ID: 9169644 [Abstract] [Full Text] [Related]
19. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G, Bregante S, Di Grazia C, Soracco M, Pitto A, Frassoni F, Bacigalupo A. Blood; 2002 Dec 01; 100(12):3930-4. PubMed ID: 12393584 [Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Millot F, Esperou H, Bordigoni P, Dalle JH, Michallet M, Michel G, Bourhis JL, Kuenz M, Blaise D, Garban F, Plouvier E, Rome A, Guilhot J, Guilhot F. Bone Marrow Transplant; 2003 Nov 01; 32(10):993-9. PubMed ID: 14595387 [Abstract] [Full Text] [Related] Page: [Next] [New Search]